966 hedge funds and large institutions have $90B invested in Biogen in 2015 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 336 increasing their positions, 371 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 371

35% less call options, than puts

Call options by funds: $1.06B | Put options by funds: $1.64B

Holders
966
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
68
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.06B
Puts
$1.64B
Net Calls
Net Calls Change

Top Buyers

1 +$951M
2 +$438M
3 +$393M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$301M
5
IC
Institutional Capital
Illinois
+$279M

Top Sellers

1 -$585M
2 -$474M
3 -$258M
4
Goldman Sachs
Goldman Sachs
New York
-$227M
5
Jennison Associates
Jennison Associates
New York
-$221M
Name Holding Trade Value Shares
Change
Change in
Stake
826
$274K
827
$274K
828
$274K
829
$273K
830
$273K
831
$273K
832
$267K
833
$266K
834
$265K
835
$264K
836
$261K
837
$258K
838
$254K
839
$253K
840
$252K
841
$251K
842
$247K
843
$245K
844
$245K
845
$242K
846
$242K
847
$239K
848
$236K
849
$236K
850
$234K